Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block

Abstract

When anti-SSA/Ro antibodies are present in sera of mothers with connective tissue diseases, the incidence of congenital heart block (CHB) has been reported to be 1-2% in live births. The risk of recurrence of CHB in a subsequent child remains limited to 10-16%. CHBs are usually complete but CHB of the first or second degree can also be observed. In some cases, CHB is associated with endocardial fibroelastosis. Late-onset cardiomyopathy may occur later in life in these children. The mortality of CHB, which is predominant in utero and in the first months of life, is an estimated 16-19%. A pacemaker is required in about 66% of cases. Curative treatment of CHB is based on fluorinated steroids (dexamethasone or betamethasone) that do cross the placenta in an active form. Guidelines are available but further studies are needed to optimize treatment.

Keywords

congenital heart block connective tissue diseases neonatal lupus syndrome pregnancy

Get full access to this article

View all access options for this article.

References

Buyon JP , Hiebert R , Copel J et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry . J Am Coll Cardiol 1998; 31: 1658-1666 .

Eronen M , Siren MK , Ekblad H , Tikanoja T , Julkunen H , Paavilainen T. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as newborn . Pediatrics 2000; 106: 86-91 .

Brucato A , Gasparini M , Vignati G et al. Isolated congenital complete heart block: longterm outcome of children and immunogenetic study . J Rheumatol 1995; 22: 541-543 .

Waltuck J , Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children . Ann Intern Med 1994; 120: 544-551 .

Neiman AR , Lee LA , Weston WL , Buyon JP. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry . J Pediatr 2000; 137: 674-680 .

Lee LA , Sokol RJ , Buyon JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry . Pediatrics 2002; 109: E11-E11 .

Press J , Uziel Y , Laxer RM , Luy L , Hamilton RM , Silverman ED. Long-term outcome of mothers of children with complete congenital heart block . Am J Med 1996; 100: 328-332 .

Lawrence S , Luy L , Laxer R , Krafchik B , Silverman E. The health of mothers of children with cutaneous neonatal lupus erythematosus differs from that of mothers of children with congenital heart block . Am J Med 2000; 108: 705-709 .

Brucato A , Franceschini F , Gasparini M et al. Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background . J Rheumatol 1995; 22: 533-540 .

10.

Brucato A , Franceschini F , Buyon JP. Neonatal lupus: long-term outcomes of mothers and children and recurrence rate . Clin Exp Rheumatol 1997; 15: 467-473 .

11.

Julkunen H , Eronen M. The rate of recurrence of isolated congenital heart block: a population-based study . Arthritis Rheum 2001; 44: 487-488 .

12.

Julkunen H , Eronen M. Long-term outcome of mothers of children with isolated heart block in Finland . Arthritis Rheum 2001; 44: 647-652 .

13.

Michaelsson M , Engle MA. Congenital complete heart block: an international study of the natural history . Cardiovasc Clin 1972; 4: 85-101 .

14.

Siren MK , Julkunen H , Kaaja R. The increasing incidence of isolated congenital heart block in Finland . J Rheumatol 1998; 25: 1862-1864 .

15.

Brucato A , Frassi M , Franceschini F et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women . Arthritis Rheum 2001; 44: 1832-1835 .

16.

Costedoat-Chalumeau N , Amoura Z , Lupoglazoff JM et al. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group . Arthritis Rheum 2004; 50: 3187-3194 .

17.

Gordon PA , Rosenthal E , Khamashta MA , Hughes GR. Absence of conduction defects in the electrocardiograms of mothers with children with congenital complete heart block . J Rheumatol 2001; 28: 366-369 .

18.

Cooley HM , Keech CL , Melny BJ , Menahem S , Morahan G , Kay TW. Monozygotic twins discordant for congenital complete heart block . Arthritis Rheum 1997; 40: 381-384 .

19.

Buyon JP , Clancy RM. Autoantibody-associated congenital heart block: TGFbeta and the road to scar . Autoimmun Rev 2005; 4: 1-7 .

20.

Miranda ME , Tseng CE , Rashbaum W et al. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes . J Immunol 1998; 161: 5061-5069 .

21.

Miranda-Carus ME , Askanase AD , Clancy RM et al. Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages . J Immunol 2000; 165: 5345-5351 .

22.

Clancy RM , Backer CB , Yin X , Kapur RP , Molad Y , Buyon JP. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta1 to the pathogenesis of autoimmune-associated congenital heart block . J Immunol 2003; 171: 3253-3261 .

23.

Clancy RM , Askanase AD , Kapur RP et al. Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block . J Immunol 2002; 169: 2156-2163 .

24.

Clancy RM , Kapur RP , Molad Y , Askanase AD , Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block . Arthritis Rheum 2004; 50: 173-182 .

25.

Herreman G , Galezewski N. Maternal connective tissue disease and congenital heart block . N Engl J Med 1985; 312: 1329-1329 .

26.

Saleeb S , Copel J , Friedman D , Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus . Arthritis Rheum 1999; 42: 2335-2345 .

27.

Schmidt KG , Ulmer HE , Silverman NH , Kleinman CS , Copel JA. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience . J Am Coll Cardiol 1991; 17: 1360-1366 .

28.

Askanase AD , Friedman DM , Copel J et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies . Lupus 2002; 11: 145-151 .

29.

Moak JP , Barron KS , Hougen TJ et al. Congenital heart block: development of late-onset cardiomyopathy, a previously under-appreciated sequela . J Am Coll Cardiol 2001; 37: 238-242 .

30.

Hogg GR. Congenital, acute lupus erythematosus associated with subendocardial fibroelastosis. Report of a case . Am J Clin Pathol 1957; 28: 648-654 .

31.

Nield LE , Silverman ED , Taylor GP et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis . Circulation 2002; 105: 843-848 .

32.

Blanford AT , Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta . Am J Obstet Gynecol 1977; 127: 264-267 .

33.

Sonesson SE , Salomonsson S , Jacobsson LA , Bremme K , Wahren-Herlenius M. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies . Arthritis Rheum 2004; 50: 1253-1261 .

34.

Buyon JP , Swersky SH , Fox HE , Bierman FZ , Winchester RJ. Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus. Experience in a mother with a predominance of SS-B (La) antibodies . Arthritis Rheum 1987; 30: 44-49 .

35.

Jaeggi ET , Fouron JC , Silverman ED , Ryan G , Smallhorn J , Hornberger LK. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease . Circulation 2004; 110: 1542-1548 .

36.

Buyon JP , Clancy RM. Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach . Semin Arthritis Rheum 2003; 33: 140-154 .

37.

Baud O , Foix-L’Helias L , Kaminski M et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants . N Engl J Med 1999; 341: 1190-1196 .

38.

Baud O , Laudenbach V , Evrard P , Gressens P. Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives . Pediatr Res 2001; 50: 706-711 .

39.

Costedoat-Chalumeau N , Amoura Z , Le Thi Hong D et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block . Ann Rheum Dis 2003; 62: 1010-1012 .

40.

Chico A , Manzanares JM , Halperin I , Martinez de Osaba MJ , Adelantado J , Webb SM. Cushing’s disease and pregnancy: report of six cases . Eur J Obstet Gynecol Reprod Biol 1996; 64: 143-146 .

41.

Costedoat-Chalumeau N , Amouna Z , Villain E , Cohen L , Piette JC. Anti-SSa/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and treatment options . Arthritis Res Ther 2005; 7: 69-73 .

42.

Nield LE , Silverman ED , Smallhorn JF et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block . J Am Coll Cardiol 2002; 40: 796-802 .